Alkynyl-coumarinyl ethers as MAO-B inhibitors

被引:45
作者
Mertens, Matthias D. [1 ]
Hinz, Sonja [1 ]
Mueller, Christa E. [1 ]
Guetschow, Michael [1 ]
机构
[1] Univ Bonn, Inst Pharmaceut, D-53121 Bonn, Germany
关键词
Alkynes; Coumarins; Distribution coefficients; Mitsunobu reaction; Monoamine oxidase; MONOAMINE-OXIDASE-B; BIOLOGICAL EVALUATION; DUAL INHIBITORS; FLUORINATED PHENYLCYCLOPROPYLAMINES; PARKINSONS-DISEASE; POTENT; DERIVATIVES; 3-PHENYLCOUMARINS; ANTAGONISTS; SCAFFOLD;
D O I
10.1016/j.bmc.2014.01.046
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In this study, alkynyl-coumarinyl ethers were developed as inhibitors of human monoamine oxidase B (MAO-B). A series of 31 new, ether-connected coumarin derivatives was synthesized via hydroxycoumarins, whose phenolic group at position 6, 7 or 8 was converted by means of the Mitsunobu reaction. The majority of the final products were produced from primary alcohols with a terminal alkyne group. The inhibitors were optimized with respect to the structure of the alkynyloxy chain and its position at the fused benzene ring as well as the residue at position 3 of the pyran-2H-one part. A hex-5-ynyloxy chain at position 7 was found to be particular advantageous. Among the 7-hex-5-ynyloxy-coumarins, the 3-methoxycarbonyl derivative 36 was characterized as a dual-acting inhibitor with IC50 values of less than 10 nM towards MAO-A and MAO-B, and the 3-(4-methoxy) phenyl derivative 44 was shown to combine strong anti-MAO-B potency (IC50 = 3.0 nM) and selectivity for MAO-B over MAO-A (selectivity > 3400-fold). (C) 2014 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1916 / 1928
页数:13
相关论文
共 50 条
  • [31] A comprehensive review on synthesis and designing aspects of coumarin derivatives as monoamine oxidase inhibitors for depression and Alzheimer's disease
    Patil, Pravin O.
    Bari, Sanjay B.
    Firke, Sandip D.
    Deshmukh, Prashant K.
    Donda, Shailesh T.
    Patil, Dilip A.
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2013, 21 (09) : 2434 - 2450
  • [32] Inhibition of monoamine oxidase B by selective adenosine A2A receptor antagonists
    Petzer, JP
    Steyn, S
    Castagnoli, KP
    Chen, JF
    Schwarzschild, MA
    Van der Schyf, CJ
    Castagnoli, N
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2003, 11 (07) : 1299 - 1310
  • [33] Discovery of a Novel Class of Potent Coumarin Monoamine Oxidase B Inhibitors: Development and Biopharmacological Profiling of 7-[(3-Chlorobenzyl)oxy]-4-[(methylamino)methyl]-2H-chromen-2-one Methanesulfonate (NW-1772) as a Highly Potent, Selective, Reversible, and Orally Active Monoamine Oxidase B Inhibitor
    Pisani, Leonardo
    Muncipinto, Giovanni
    Miscioscia, Teresa Fabiola
    Nicolotti, Orazio
    Leonetti, Francesco
    Catto, Marco
    Caccia, Carla
    Salvati, Patricia
    Soto-Otero, Ramon
    Mendez-Alvarez, Estefania
    Passeleu, Celine
    Carotti, Angelo
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (21) : 6685 - 6706
  • [34] Antagonists for the Orphan G-Protein-Coupled Receptor GPR55 Based on a Coumarin Scaffold
    Rempel, Viktor
    Volz, Nicole
    Glaeser, Franziska
    Nieger, Martin
    Braese, Stefan
    Mueller, Christa E.
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2013, 56 (11) : 4798 - 4810
  • [35] 7-Alkyl-3-benzylcoumarins: A Versatile Scaffold for the Development of Potent and Selective Cannabinoid Receptor Agonists and Antagonists
    Rempel, Viktor
    Volz, Nicole
    Hinz, Sonja
    Karcz, Tadeusz
    Meliciani, Irene
    Nieger, Martin
    Wenzel, Wolfgang
    Braese, Stefan
    Mueller, Christa E.
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (18) : 7967 - 7977
  • [36] SYNTHESIS OF COUMARINS AS SUBTYPE-SELECTIVE INHIBITORS OF MONOAMINE-OXIDASE
    RENDENBACHMULLER, B
    SCHLECKER, R
    TRAUT, M
    WEIFENBACH, H
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1994, 4 (10) : 1195 - 1198
  • [37] Riederer Peter, 2011, Exp Neurobiol, V20, P1, DOI 10.5607/en.2011.20.1.1
  • [38] Multipotent MAO and cholinesterase inhibitors for the treatment of Alzheimer's disease: Synthesis, pharmacological analysis and molecular modeling of heterocyclic substituted alkyl and cycloalkyl propargyl amine
    Samadi, Abdelouahid
    de los Rios, Cristobal
    Bolea, Irene
    Chioua, Mourad
    Iriepa, Isabel
    Moraleda, Ignacio
    Bartolini, Manuela
    Andrisano, Vincenza
    Galvez, Enrique
    Valderas, Carolina
    Unzeta, Mercedes
    Marco-Contelles, Jose
    [J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2012, 52 : 251 - 262
  • [39] Monoamine Oxidase B Inhibitors for the Treatment of Parkinson's Disease A Review of Symptomatic and Potential Disease-Modifying Effects
    Schapira, Anthony H. V.
    [J]. CNS DRUGS, 2011, 25 (12) : 1061 - 1071
  • [40] Synthesis and selective human monoamine oxidase inhibition of 3-carbonyl, 3-acyl, and 3-carboxyhydrazido coumarin derivatives
    Secci, Daniela
    Carradori, Simone
    Bolasco, Adriana
    Chimenti, Paola
    Yanez, Matilde
    Ortuso, Francesco
    Alcaro, Stefano
    [J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2011, 46 (10) : 4846 - 4852